Literature DB >> 17244162

Dysaccommodation of the stomach: therapeutic nirvana?

R Bisschops1, J Tack.   

Abstract

Functional dyspepsia (FD) is a highly prevalent gastrointestinal disorder and has a complex pathophysiology. Impaired fundic relaxation in response to a meal is present in 40% of patients with FD. This review focuses on impaired gastric accommodation of the stomach as a pathophysiological mechanism and the possible therapeutic targets that can be derived from the current knowledge of the neuroregulation of the accommodation reflex. First the different means of gastric accommodation assessment are described and the relationship between symptoms and impaired gastric accommodation. The different therapeutic options are subsequently discussed in view of their molecular target, based on the different receptor subtypes involved in the accommodation reflex. Although impaired gastric accommodation is highly prevalent in dyspeptic patients and basic knowledge about the accommodation reflex enables to develop pathophysiologically targeted therapies, it is unlikely that therapies aimed at dysaccommodation of the stomach will lead to symptom relief in all dyspeptic patients. A major challenge is the development of methods that readily identify impaired accommodation in clinical practice.

Entities:  

Mesh:

Year:  2007        PMID: 17244162     DOI: 10.1111/j.1365-2982.2006.00863.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  6 in total

Review 1.  Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.

Authors:  John M Rosen; Jose T Cocjin; Jennifer V Schurman; Jennifer M Colombo; Craig A Friesen
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

2.  Oxytocin-immunoreactive innervation of identified neurons in the rat dorsal vagal complex.

Authors:  I J Llewellyn-Smith; D O Kellett; D Jordan; K N Browning; R Alberto Travagli
Journal:  Neurogastroenterol Motil       Date:  2011-12-21       Impact factor: 3.598

3.  A Critical Review of the Current Clinical Landscape of Gastroparesis.

Authors:  Chimi L Fosso; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

Review 4.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

Review 5.  Potential Mechanisms of Acupuncture for Functional Dyspepsia Based on Pathophysiology.

Authors:  Na-Na Yang; Chun-Xia Tan; Lu-Lu Lin; Xin-Tong Su; Yue-Jie Li; Ling-Yu Qi; Yu Wang; Jing-Wen Yang; Cun-Zhi Liu
Journal:  Front Neurosci       Date:  2022-01-25       Impact factor: 4.677

Review 6.  DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia.

Authors:  Yong Sam Kwon; Miwon Son
Journal:  Biomol Ther (Seoul)       Date:  2013-05-30       Impact factor: 4.634

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.